List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 569 studies with search of: "Fludarabine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: fludarabine and rituximab;   Drug: fludarabine, rituximab, pixantrone
2 Recruiting Plerixafor and Granulocyte Colony-Stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
Conditions: Stem Cell Transplantation;   Leukemia
Interventions: Drug: Plerixafor;   Drug: Filgrastim;   Drug: Fludarabine;   Drug: Busulfan;   Procedure: Allogeneic blood stem cell transplant;   Drug: ATG (Thymoglobulin)
3 Completed Busulfan and Fludarabine in Patients With AML and MDS
Condition: Leukemia
Interventions: Drug: Busulfan;   Drug: Fludarabine
4 Recruiting Double Cord Blood Transplantation
Conditions: Leukemia;   Lymphoma;   Neuroblastoma;   Immunodeficiencies;   Anemia
Interventions: Drug: TBI, Thiotepa, Cyclophosphamide, ATG;   Drug: Busulfan, Melphalan, Rabbit ATG;   Drug: Busulfan, Fludarabine, Alemtuzumab;   Drug: Busulfan, Fludarabine, Rabbit ATG;   Drug: Fludarabine, Cyclophosphamide, ATG;   Drug: Busulfan, Cyclosphosphamide, Rabbit ATG,
5 Not yet recruiting Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Patients Previously Treated With Rituximab
Condition: Follicular Lymphoma
Interventions: Drug: VELCADE and fludarabine;   Drug: rituximab and fludarabine
6 Recruiting Fludarabine, Bendamustine and Rituximab Conditioning for Patients With Lymphoid Malignancies
Conditions: Leukemia;   Lymphoma
Interventions: Drug: Bendamustine;   Drug: Rituximab;   Drug: Fludarabine;   Procedure: Stem Cell Transplant (SCT)
7 Active, not recruiting Fludara Plus Alemtuzumab (Campath, MabCampath) vs Fludara Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
Condition: B-Cell Lymphocytic Leukemia
Interventions: Biological: alemtuzumab (Campath, MabCampath); FluCAM [Fludara + Campath];   Biological: fludarabine phosphate (Fludara)
8 Active, not recruiting Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor
Conditions: Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma;   Allogeneic Marrow Transplant
Interventions: Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF;   Drug: BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
9 Active, not recruiting Imatinib Mesylate, Busulfan, Fludarabine, and ATG for CML Patients
Condition: Leukemia
Interventions: Drug: Imatinib Mesylate;   Drug: Fludarabine;   Drug: Busulfan;   Drug: ATG
10 Active, not recruiting Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
Condition: Hematologic Malignancies
Interventions: Drug: Busulfan;   Drug: Fludarabine
11 Recruiting Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Chronic Myeloid Leukemia
Interventions: Drug: Clofarabine;   Drug: Busulfan;   Drug: Fludarabine
12 Recruiting Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
Conditions: AML;   MDS;   ALL;   CML;   Lymphoma
Intervention: Drug: fludarabine phosphate, busulfan
13 Recruiting Study Looking to See How Effective Fludarabine and Rituximab Followed by Bexxar Are for CLL or SLL
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma
Interventions: Drug: Fludarabine;   Drug: Rituximab;   Drug: 131TOSITUMOMAB (BEXXAR®)
14 Recruiting A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Gene Directed Enzyme Prodrug Therapy, FP253/Fludarabine
15 Recruiting Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
Conditions: Richter's Transformation;   Leukemia
Interventions: Drug: Oxaliplatin;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Rituximab
16 Active, not recruiting FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Mitoxantrone;   Drug: Rituximab;   Drug: Filgrastim
17 Active, not recruiting Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Novantrone;   Drug: Decadron;   Drug: Rituximab;   Drug: Interferon;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Ara-C;   Drug: Methyl-Prednisolone;   Drug: Procarbazine;   Drug: Prednisone
18 Recruiting FM 140 vs FM100 Study in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Melphalan;   Drug: Fludarabine;   Procedure: Stem Cell Infusion;   Drug: Rituximab
19 Recruiting Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Cyclophosphamide;   Drug: Fludarabine
20 Recruiting Busulfan and Fludarabine Followed by Post-Transplant Cyclophosphamide
Conditions: Hematologic Diseases;   Leukemia;   Lymphoma;   Myeloma
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: Cyclophosphamide

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services